Supplemental Annuity Collective Trust (SACT) of New Jersey’s Royalty Pharma RPRX Stock Holding History

Supplemental Annuity Collective Trust (SACT) of New Jersey’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17,000	Closed	-$657K	–	351
2025 Q4	$657K	Hold	17,000	–	–	0.17%	130
2025 Q3	$600K	Hold	17,000	–	–	0.16%	143
2025 Q2	$613K	Hold	17,000	–	–	0.17%	134
2025 Q1	$529K	Hold	17,000	–	–	0.17%	142
2024 Q4	$434K	Hold	17,000	–	–	0.13%	163
2024 Q3	$481K	Hold	17,000	–	–	0.14%	156
2024 Q2	$448K	Hold	17,000	–	–	0.14%	154
2024 Q1	$516K	Hold	17,000	–	–	0.16%	144
2023 Q4	$478K	Buy	+17,000	New	+$467K	0.17%	143

Other funds holding RPRX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Supplemental Annuity Collective Trust (SACT) of New Jersey's RPRX Position: Q1 2026 in Review

Supplemental Annuity Collective Trust (SACT) of New Jersey sold out of Royalty Pharma (RPRX) in Q1 2026, closing a stake of 17,000 shares — an estimated $657K sold.

Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in RPRX in Q4 2023 and held it in 9 quarters. The position peaked at $657K in Q4 2025. 590 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

Supplemental Annuity Collective Trust (SACT) of New Jersey reported no remaining Royalty Pharma position as of Q1 2026 after selling out during the quarter.
Supplemental Annuity Collective Trust (SACT) of New Jersey sold 17,000 Royalty Pharma shares in Q1 2026, an estimated $657K.
Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in Royalty Pharma in Q4 2023 and held it in 9 quarters.
Supplemental Annuity Collective Trust (SACT) of New Jersey's Royalty Pharma position peaked at $657K in Q4 2025.
590 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Supplemental Annuity Collective Trust (SACT) of New Jersey's 13F filing for Q1 2026, filed 1 May 2026.